Trial · NCT07568496
Greater Occipital Nerve Block for Migraine With Medication Overuse Headache
NCT07568496, Not applicable, Recruiting, Mahidol University
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Greater Occipital Nerve Block for Migraine With Medication Overuse Headache. Trials, record NCT07568496. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07568496
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Greater Occipital Nerve Block for Migraine With Medication Overuse Headache
- NCT number
- NCT07568496
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 130 participants, estimated
- Lead sponsor
- Mahidol University
- Conditions
- Migraine Disorders, Medication Overuse Headache, Greater Occipital Nerve Block
- Interventions
- Lidocaine 2% and Methylprednisolone 80 mg, Placebo
- First posted
- 2026-05-05
- Last updated
- 2026-10-08
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percentage of patients with Medication Overuse Headache (MOH) | At the end of month 1 and month 3 after detoxification. | The percentage of participants diagnosed with Medication Overuse Headache (MOH) according to ICHD criteria. |
| Secondary | Percentage of patients achieving 50% improvement in migraine | At the end of month 3. | The percentage of patients with at least a 50% reduction in monthly headache days compared to baseline (month -1). |
| Secondary | Change in monthly headache days | Baseline (month -1) and month 3. | The mean change in the number of headache days per month from baseline to month 3. |
| Secondary | Change in mean headache severity | Baseline (month -1) and month 3. | The change in mean headache severity scores measured by the Visual Analog Scale (VAS). 0 being no pain and 10 being the worst pain |
| Secondary | Change in Migraine Disability Assessment (MIDAS) Score | Baseline (month -1) and month 3. | Evaluation of the change in disability caused by migraines using the MIDAS questionnaire. MIDAS score ranges from 0 to 270 with the higher score, the worse disability. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers13
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07568496
GET https://conductscience.org/api/trials/v1/NCT07568496/registered